Your browser doesn't support javascript.
loading
Patient Reported Improvement in Quality of Life Associated With Successful Laser Hair Reduction at Hemodialysis Site With 1064-nm Nd:YAG Laser.
J Drugs Dermatol ; 17(7): 794-795, 2018 Jul 01.
Article em En | MEDLINE | ID: mdl-30005102
Laser hair reduction is a well-established modality for a wide range of medical indications. Laser hair reduction can be beneficial for hemodialysis patients who undergo repeated adhesive tape application and removal at their hemodialysis site during hemodialysis sessions. There is a paucity of published literature on efficacious laser hair removal treatments for hemodialysis patients. Herein, we present a case of a 50-year-old male (Fitzpatrick III) with end-stage renal disease on hemodialysis, who achieved successful laser hair reduction at his hemodialysis vascular access site with five sessions of a neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1064 nm) to improve his quality of life by reducing the hair burden at the adhesive tape site application. We recommend providing this safe and effective hair reduction treatment option for hemodialysis patients given the decreased quality of life associated with end stage renal disease and hemodialysis. J Drugs Dermatol. 2018;17(7):794-795.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Derivação Arteriovenosa Cirúrgica / Diálise Renal / Lasers de Estado Sólido / Remoção de Cabelo Tipo de estudo: Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Revista: J Drugs Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Derivação Arteriovenosa Cirúrgica / Diálise Renal / Lasers de Estado Sólido / Remoção de Cabelo Tipo de estudo: Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Revista: J Drugs Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article